Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?

Group 1 - Assertio (ASRT) is a notable stock in the Medical sector, currently outperforming its peers with a year-to-date return of 31.2% compared to the sector average of 0.5% [4] - The Zacks Rank for Assertio is 2 (Buy), indicating a favorable outlook based on earnings estimate revisions and improving earnings prospects [3] - Over the past 90 days, the Zacks Consensus Estimate for Assertio's full-year earnings has increased by 6.6%, reflecting stronger analyst sentiment [4] Group 2 - Assertio is part of the Medical - Drugs industry, which consists of 143 companies and currently ranks 87 in the Zacks Industry Rank, while the industry has seen an average loss of 1.3% this year [6] - Another outperforming stock in the Medical sector is Aura Biosciences, Inc. (AURA), which has gained 14.5% year-to-date and has a Zacks Rank of 2 (Buy) [5] - The Medical - Biomedical and Genetics industry, where Aura operates, has 447 stocks and has increased by 6.6% since the beginning of the year [7]